Targeting rickettsia.
Walker
David H
DH
Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, USA.
D000818:Animals; D034961:Antigens, Nuclear / Q000378:metabolism*; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000378:metabolism*; D024881:Drug Resistance, Bacterial; D004705:Endocytosis; D006801:Humans; D000072200:Ku Autoantigen; D011485:Protein Binding; D012282:Rickettsia Infections / Q000188:drug therapy*; D020114:Rickettsia conorii / Q000378:metabolism* / Q000472:pathogenicity; D015398:Signal Transduction; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
D034961:Antigens, Nuclear; D004268:DNA-Binding Proteins; D044767:Ubiquitin-Protein Ligases; C000606509:Xrcc6 protein, human; D000072200:Ku Autoantigen